Maltoheptaose Promotes Nanoparticle Internalization by Escherichia coli
dc.contributor.author | Jayawardena, H. Surangi N. | |
dc.contributor.author | Jayawardana, Kalana W. | |
dc.contributor.author | Chen, Xuan | |
dc.contributor.author | Yan, Mingdi | |
dc.date | 2022-08-11T08:08:13.000 | |
dc.date.accessioned | 2022-08-23T15:46:45Z | |
dc.date.available | 2022-08-23T15:46:45Z | |
dc.date.issued | 2013-05-08 | |
dc.date.submitted | 2013-07-15 | |
dc.identifier.doi | 10.13028/czk1-4r20 | |
dc.identifier.uri | http://hdl.handle.net/20.500.14038/27825 | |
dc.description.abstract | Nanoparticles conjugated with D-maltoheptaose (G7) showed a striking increase in the surface adherence and internalization by E. coli. This applies to silica nanoparticles (SNP), magnetic nanoparticles (MNP), silica-coated magnetic nanoparticles (SMNP) and silica-coated quantum dots (SQDs) ranging from a few to over a hundred nanometers in size, as well as wild type E. coli ATCC 33456, ORN 178, ORN 208 with the maltodextrin transport channel and the LamB mutant JW 3392-1 (Fig. 1). TEM images including the thin section samples revealed the uptake of nanoparticles in cell walls and inside the cytoplasm (Fig. 2). Unfunctionalized nanoparticles and nanoparticles functionalized with β-cyclodextrin (CD) showed little or no binding to the E. coli cell surface, and no obvious internalization of the nanoparticles was observed. D-Mannose-functionalized nanoparticles bound to the pili of E. coli ORN 178 through the well-known Man-binding lectin (FimH) rather than cell internalization. Surface ligands that can improve the uptake of nanomaterials to bacterial cells should provide a powerful means of targeting a payload delivery to a potential disease causing strain. Work is underway to develop nanomaterial delivery systems for multidrug resistance bacteria. | |
dc.format | youtube | |
dc.language.iso | en_US | |
dc.rights | Copyright the Author(s) | |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-sa/3.0/ | |
dc.subject | Biochemistry | |
dc.subject | Chemistry | |
dc.subject | Nanoscience and Nanotechnology | |
dc.subject | Therapeutics | |
dc.subject | Translational Medical Research | |
dc.title | Maltoheptaose Promotes Nanoparticle Internalization by Escherichia coli | |
dc.type | Poster Abstract | |
dc.identifier.legacyfulltext | https://escholarship.umassmed.edu/cgi/viewcontent.cgi?article=1137&context=cts_retreat&unstamped=1 | |
dc.identifier.legacycoverpage | https://escholarship.umassmed.edu/cts_retreat/2013/posters/44 | |
dc.identifier.contextkey | 4313682 | |
refterms.dateFOA | 2022-08-23T15:46:46Z | |
html.description.abstract | <p>Nanoparticles conjugated with D-maltoheptaose (G7) showed a striking increase in the surface adherence and internalization by E. coli. This applies to silica nanoparticles (SNP), magnetic nanoparticles (MNP), silica-coated magnetic nanoparticles (SMNP) and silica-coated quantum dots (SQDs) ranging from a few to over a hundred nanometers in size, as well as wild type E. coli ATCC 33456, ORN 178, ORN 208 with the maltodextrin transport channel and the LamB mutant JW 3392-1 (Fig. 1). TEM images including the thin section samples revealed the uptake of nanoparticles in cell walls and inside the cytoplasm (Fig. 2). Unfunctionalized nanoparticles and nanoparticles functionalized with β-cyclodextrin (CD) showed little or no binding to the E. coli cell surface, and no obvious internalization of the nanoparticles was observed. D-Mannose-functionalized nanoparticles bound to the pili of E. coli ORN 178 through the well-known Man-binding lectin (FimH) rather than cell internalization. Surface ligands that can improve the uptake of nanomaterials to bacterial cells should provide a powerful means of targeting a payload delivery to a potential disease causing strain. Work is underway to develop nanomaterial delivery systems for multidrug resistance bacteria.</p> | |
dc.identifier.submissionpath | cts_retreat/2013/posters/44 |